These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 36445941)
1. Effect of calcitriol and calcium on basal ganglia calcification in hypoparathyroidism: experimental models. Kar P; Goswami R J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36445941 [TBL] [Abstract][Full Text] [Related]
2. Osteogenic Mechanisms of Basal Ganglia Calcification and its ex vivo Model in the Hypoparathyroid Milieu. Kar P; Millo T; Saha S; Mahtab S; Agarwal S; Goswami R Endocrinology; 2021 Apr; 162(4):. PubMed ID: 33539507 [TBL] [Abstract][Full Text] [Related]
3. Expression of osteogenic molecules in the caudate nucleus and gray matter and their potential relevance for Basal Ganglia calcification in hypoparathyroidism. Goswami R; Millo T; Mishra S; Das M; Kapoor M; Tomar N; Saha S; Roy TS; Sreenivas V J Clin Endocrinol Metab; 2014 May; 99(5):1741-8. PubMed ID: 24552219 [TBL] [Abstract][Full Text] [Related]
4. Prevalence and progression of basal ganglia calcification and its pathogenic mechanism in patients with idiopathic hypoparathyroidism. Goswami R; Sharma R; Sreenivas V; Gupta N; Ganapathy A; Das S Clin Endocrinol (Oxf); 2012 Aug; 77(2):200-6. PubMed ID: 22288727 [TBL] [Abstract][Full Text] [Related]
5. Basal Ganglia Calcification Is Associated With Local and Systemic Metabolic Mechanisms in Adult Hypoparathyroidism. Zavatta G; Tebben PJ; McCollough CH; Yu L; Vrieze T; Clarke BL J Clin Endocrinol Metab; 2021 Jun; 106(7):1900-1917. PubMed ID: 33788935 [TBL] [Abstract][Full Text] [Related]
6. 1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders. Yasuda T; Nakajima H Endocrinol Jpn; 1984 Aug; 31(4):407-15. PubMed ID: 6097438 [TBL] [Abstract][Full Text] [Related]
7. Basal ganglia calcification in hypoparathyroidism and pseudohypoparathyroidism: local and systemic metabolic mechanisms. Zavatta G; Clarke BL J Endocrinol Invest; 2021 Feb; 44(2):245-253. PubMed ID: 32661948 [TBL] [Abstract][Full Text] [Related]
8. Alfacalcidol vs Calcitriol in the Management of Patient With Hypoparathyroidism: A Randomized Controlled Trial. Saha S; Sreenivas V; Goswami R J Clin Endocrinol Metab; 2021 Jun; 106(7):2092-2102. PubMed ID: 33616655 [TBL] [Abstract][Full Text] [Related]
9. Effect of vitamin D treatment in hypoparathyroid patients: a study on calcium, phosphate and magnesium homeostasis. Mortensen L; Hyldstrup L; Charles P Eur J Endocrinol; 1997 Jan; 136(1):52-60. PubMed ID: 9037127 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of subcutaneous recombinant parathyroid hormone (1-84) in patients with hypoparathyroidism: an open-label, single-dose, phase I study. Clarke BL; Kay Berg J; Fox J; Cyran JA; Lagast H Clin Ther; 2014 May; 36(5):722-36. PubMed ID: 24802860 [TBL] [Abstract][Full Text] [Related]
12. Effects of parathyroid hormone rhPTH(1-84) on phosphate homeostasis and vitamin D metabolism in hypoparathyroidism: REPLACE phase 3 study. Clarke BL; Vokes TJ; Bilezikian JP; Shoback DM; Lagast H; Mannstadt M Endocrine; 2017 Jan; 55(1):273-282. PubMed ID: 27734257 [TBL] [Abstract][Full Text] [Related]
13. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
14. Effect of basal ganglia calcification on its glucose metabolism and dopaminergic function in idiopathic hypoparathyroidism. Modi S; Arora G; Bal CS; Sreenivas V; Kailash S; Sagar R; Goswami R Clin Endocrinol (Oxf); 2015 Oct; 83(4):563-71. PubMed ID: 25366923 [TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of PTH 1-34 and 1-84 Therapy in Chronic Hypoparathyroidism: A Meta-Analysis of Prospective Trials. Puliani G; Hasenmajer V; Simonelli I; Sada V; Pofi R; Minnetti M; Cozzolino A; Napoli N; Pasqualetti P; Gianfrilli D; Isidori AM J Bone Miner Res; 2022 Jul; 37(7):1233-1250. PubMed ID: 35485213 [TBL] [Abstract][Full Text] [Related]
16. Transient Increased Calcium and Calcitriol Requirements After Discontinuation of Human Synthetic Parathyroid Hormone 1-34 (hPTH 1-34) Replacement Therapy in Hypoparathyroidism. Gafni RI; Guthrie LC; Kelly MH; Brillante BA; Christie CM; Reynolds JC; Yovetich NA; James R; Collins MT J Bone Miner Res; 2015 Nov; 30(11):2112-8. PubMed ID: 25990370 [TBL] [Abstract][Full Text] [Related]
17. Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients. Saki F; Kassaee SR; Salehifar A; Omrani GHR BMC Nephrol; 2020 May; 21(1):176. PubMed ID: 32398014 [TBL] [Abstract][Full Text] [Related]
18. Management of hypoparathyroidism during pregnancy--report of twelve cases. Callies F; Arlt W; Scholz HJ; Reincke M; Allolio B Eur J Endocrinol; 1998 Sep; 139(3):284-9. PubMed ID: 9758437 [TBL] [Abstract][Full Text] [Related]
19. Vitamin D metabolism in hypoparathyroidism. Lund B; Sørensen OH; Lund B; Bishop JE; Norman AW J Clin Endocrinol Metab; 1980 Sep; 51(3):606-10. PubMed ID: 6967875 [TBL] [Abstract][Full Text] [Related]
20. Effects of 1alpha-hydroxy-vitamin D3 and 1,25-dihydroxy-vitamin D3 on calcium and phosphorus metabolism in hypoparathyroidism. Neer RM; Holick MF; DeLuca HF; Potts JT Metabolism; 1975 Dec; 24(12):1403-13. PubMed ID: 1196134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]